SENP1 Disrupts SREBP2 Degradation to Drive Cholesterol Synthesis
A study in Cancer & Metabolism reveals that SENP1 drives de novo cholesterol synthesis in prostate cancer by deSUMOylating SREBP2, ...
A study in Cancer & Metabolism reveals that SENP1 drives de novo cholesterol synthesis in prostate cancer by deSUMOylating SREBP2, ...
A nationwide Dutch registry study shows real-world olaparib therapy achieved a 13.4-month median overall survival in BRCA-mutated prostate cancer, with ...
An observational study of 1,955 patients with urological cancers found that G8 and functional competence had low concordance but were ...
A systematic scoping review finds that current AI evidence does not support omitting extended pelvic lymph-node dissection after a negative ...
The study, published in EJNMMI Radiopharmacy and Chemistry, utilized two distinct radiotracers: In-PSMA-I&T for targeting PSMA-positive lesions and Tc-DPD for ...
A retrospective study in Diagnostic Pathology found that a biopsy-trained AI algorithm achieved 94.3% sensitivity for detecting incidental prostate adenocarcinoma ...
A two-center study developed a biparametric MRI habitat analysis framework that effectively identifies pathologically high-risk prostate cancer, showing superior discrimination ...
Ultrasound-guided nanobubbles co-delivering siFGFR1 and enzalutamide inhibited drug-resistant prostate cancer cells and reduced tumor growth in preclinical models without observed ...
A narrative review in the African Journal of Urology outlines adaptive strategies for managing metastatic prostate cancer in low- and ...
A clinical case report documents an asymptomatic 73-year-old prostate cancer patient whose biochemical recurrence led to the rare detection of ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine